Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple Sclerosis
- DOI
- 10.1007/s40120-025-00784-0
- Published
- 2025-07-13
- Container
- Neurology and Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40120-025-00784-0,
title = {Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple Sclerosis},
author = {Stephen L. Hauser and Jeffrey A. Cohen and Jérôme de Sèze and Sven G. Meuth and Paul S. Giacomini and Jin Nakahara and Celia Oreja-Guevara and Derrick Robertson and Sibyl Wray and Alit Bhatt and Xixi Hu and Jing Xi and Rebecca Piccolo and Valentine Jehl and Roseanne Sullivan and Ibolya Boer and Heinz Wiendl and Ludwig Kappos},
year = {2025},
journal = {Neurology and Therapy},
doi = {10.1007/s40120-025-00784-0},
url = {https://doi.org/10.1007/s40120-025-00784-0}
}RIS
TY - JOUR TI - Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple Sclerosis AU - Stephen L. Hauser AU - Jeffrey A. Cohen AU - Jérôme de Sèze AU - Sven G. Meuth AU - Paul S. Giacomini AU - Jin Nakahara AU - Celia Oreja-Guevara AU - Derrick Robertson AU - Sibyl Wray AU - Alit Bhatt AU - Xixi Hu AU - Jing Xi AU - Rebecca Piccolo AU - Valentine Jehl AU - Roseanne Sullivan AU - Ibolya Boer AU - Heinz Wiendl AU - Ludwig Kappos PY - 2025 JO - Neurology and Therapy DO - 10.1007/s40120-025-00784-0 UR - https://doi.org/10.1007/s40120-025-00784-0 ER -
APA
Hauser, S. L., Cohen, J. A., Sèze, J. D., Meuth, S. G., Giacomini, P. S., Nakahara, J., Oreja-Guevara, C., Robertson, D., Wray, S., Bhatt, A., Hu, X., Xi, J., Piccolo, R., Jehl, V., Sullivan, R., Boer, I., Wiendl, H., & Kappos, L. (2025). Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple Sclerosis. Neurology and Therapy. https://doi.org/10.1007/s40120-025-00784-0
Source records
- crossref · retrieved 2026-09-26T10:07:45.070Z